{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Amicus Therapeutics, Inc."},"Symbol":{"label":"Symbol","value":"FOLD"},"Address":{"label":"Address","value":"3675 MARKET STREET, PHILADELPHIA, Pennsylvania, 19104, United States"},"Phone":{"label":"Phone","value":"+1 215 921-7600"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio."},"CompanyUrl":{"label":"Company Url","value":"https://www.amicusrx.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Bradley Lewis Campbell","title":"President, Chief Executive Officer & Director"},{"name":"Jill Weimer","title":"Chief Science Officer"},{"name":"Pat Oâ€™Sullivan","title":"Chief Technical Operations Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}